SOTATERCEPT, sotatercept, sotatercept, SOTATERCEPT clinical trials

A Phase 2, Multicenter, Single-blinded, Randomized Study to Evaluate the Pharmacokinetics and Safety of Sotatercept (MK-7962) Administered Using Either a Weight-based or Weight-banded Approach in Participants With Pulmonary Arterial Hypertension (PAH) on Standard of Care

This study is looking at a new medicine called sotatercept for people with pulmonary arterial hypertension (PAH). Researchers want to see how the body handles the medicine and check for any side effects. It’s a randomised study, meaning some people will get different doses.